Gene expression profiling distinguishes proneural glioma stem cells from mesenchymal glioma stem cells

Genomics Data

Volumn 5, Issue , 2015, Pages 333-336

  Chandran, Uma R ^a   Luthra, Soumya ^a   Santana Santos, Lucas ^a   Mao, Ping ^b,h   Kim, Sung Hak ^b   Minata, Mutsuko ^b   Li, Jianfeng ^a,e,g   Benos, Panayiotis V ^a   DeWang, Mao ^h   Hu, Bo ^d   Cheng, Shi Yuan ^d   Nakano, Ichiro ^b,c   Sobol, Robert W ^a,e,f,g  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^f UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^g University of South Alabama Mitchell Cancer Institute   (United States)

^h XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Glioblastoma; Microarray; Normalization; The Cancer Genome Atlas Project

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE 1A3; UNCLASSIFIED DRUG;

ARTICLE; CELL HETEROGENEITY; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLIOMA; GLIOMA STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYMAL GLIOMA STEM CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PRONEURAL GLIOMA STEM CELL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; UPREGULATION;

MUS;

EID: 84937207618     PISSN: 22135960     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gdata.2015.07.007     Document Type: Article

References (12)

1. Mao P., Joshi K., Li J., et al. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(21):8644-8649. 10.1073/pnas.1221478110.
2. Nakano I., Joshi K., Visnyei K., et al. Siomycin A targets brain tumor stem cells partially through a MELK-mediated pathway. Neuro-Oncology 2011, 13(6):622-634. 10.1093/neuonc/nor023.
3. Jijiwa M, Demir H, Gupta S, et al. CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway. Lesniak MS, PLoS One. 2011;6(9): e24217, . doi:10.1371/journal.pone.0024217.
4. Aad G., et al. Search for production of resonant states in the photon-jet mass distribution using pp collisions at radicals=7 TeV collected by the ATLAS detector. Phys. Rev. Lett. 2012, 108(21):211802.
5. Nakano I., et al. Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells. J. Neurosci. Res. 2008, 86(1):48-60. 10.1002/jnr.21471.
6. Dougherty J.D., et al. PBK/TOPK, a proliferating neural progenitor-specific mitogen-activatedprotein kinase kinase. J. Neurosci. 2005, 25(46):10773-10785.
7. Miyazaki T., et al. Telomestatin impairs glioma stem cell survival and growth through the disruption of telomeric G-quadruplex and inhibition of the proto-oncogene, c-Myb. Clin. Cancer Res. 2012, 18(5):1268-1280.
8. Jijiwa M., et al. CD44v6 regulates growth of brain tumor stem cells partially through theAKT-mediated pathway. PLoS One 2011, 6(9):e24217.
9. Wang X., Kang D.D., Shen K., et al. An R package suite for microarray meta-analysis in quality control, differentially expressed gene analysis and pathway enrichment detection. Bioinformatics 2012, 28(19):2534-2536. 10.1093/bioinformatics/bts485.
10. Verhaak R.G., et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010, 17(1):98-110.
11. Phillips H.S., et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006, 9(3):157-173.
12. Johnson W.E., Li C., Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007, 8(1):118-127.